Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management
Horlocker, T.T.; Heit, J.A.
Anesthesia and Analgesia 85(4): 874-885
1997
ISSN/ISBN: 0003-2999 PMID: 9322474 Document Number: 481688
Document emailed within 1 workday
Related Documents
Kaiser, B.; Kirchmaier, C.M.; Breddin, H.K.; Fu, K.; Fareed, J. 1999: Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis Seminars in Thrombosis and Hemostasis 25(Suppl 3): 35-42Vallano, A.; Arnau, J.M.; Vallés, J.A. 1991: Prophylaxis of venous thrombosis and low-molecular-weight heparin Medicina Clinica 97(7): 272-275
Sturm, D.; Vazdar, L.; Bagatin, D.; Sakic, K.; Hrgovic, Z. 2012: Perioperative PAI-1 values in surgically treated colorectal carcinoma patients under low molecular weight heparin thromboprophylaxis Minerva Chirurgica 67(4): 343-354
Velut, J.G.; Boubli, L.; Lheureux, G.; d'Ercole, C.; Harlé, J.R.; Bagnères, D.; Frances, Y. 2001: Low-molecular-weight heparin prophylaxis during pregnancy: a retrospective study in 119 women Presse Medicale 30(13): 635
Nikolov, A.; Kovachev, I.; Petkov, I.; Dimitrov, A. 2000: Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics Akusherstvo i Ginekologiia 39(3): 35-40
Borris, L.C.; Lassen, M.R.; Jensen, H.P.; Andersen, B.S.; Poulsen, K.A. 1994: Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations International Journal of Clinical Pharmacology and Therapeutics 32(5): 262-268
Bacher, P.; Horst, B.; Breyer, H.G.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients Seminars in Thrombosis and Hemostasis 19(Suppl 1): 73-78
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Tapson, V.F.; Hull, R.D. 1995: Management of venous thromboembolic disease. the impact of low-molecular-weight heparin Clinics in Chest Medicine 16(2): 281-294
Bergqvist, D.; Wiklund, L. 2000: Caution for prophylaxis of thrombosis in connection with spinal anesthesia. Risk of hemorrhage when low-molecular-weight heparin is administered in epidural/spinal anesthesia Lakartidningen 97(49): 5762; 5765
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125